The GeneXpert diagnostic testing technology from the US corporation Cepheid, and its parent company Danaher, has revolutionised rapid, accurate diagnosis of tuberculosis (TB) and other diseases, since entering the market in 2010. Yet, due to the high cost of the GeneXpert test cartridges, many countries are not able to scale up testing for all people who need lifesaving diagnosis and subsequent treatment.
The Public Health Center of the Ministry of Ukraine (PHC) sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve equitable access to the lifesaving TB drug bedaquiline in ...
Civil society organisations, communities affected by tuberculosis (TB), and partner institutions in Ukraine sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve ...
Civil society organisations, communities affected by tuberculosis (TB), and partner institutions in Moldova sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve ...
Civil society organisations, communities affected by tuberculosis (TB), and partner institutions in Azerbaijan sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve ...
MSF and other CSOs sent a letter to Johnson & Johnson, calling on the pharmaceutical corporation not to enforce its secondary patents on TB drug bedaquiline
MSF and CSOs urge the European Council to reject the introduction of transferable exclusivity vouchers (TEVs) for the development of antimicrobial drugs